Image
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login

Argos Therapeutics Initiates Phase 2 Trial in Renal Cell Carcinoma for its Arcelis™ Personalized Immunotherapy Platform

admin September 10, 2008 Portfolio News

Learn More-External Link

Back

Topics

News Archives

Image
Privacy Policy Terms of Use©2022 Lumira Ventures
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login